LOGEX and P95 to jointly build the international infectious disease observatory ARWEN ID

Healthcare analytics provider LOGEX and P95, a company specialized in epidemiology of infectious diseases, have signed an agreement to jointly create an international infectious disease observatory. The goal of the observatory is to offer an international platform for research of infectious diseases like COVID-19, RSV, Influenza, Norovirus and other infections that may have a significant health impact in Europe. Additionally, the platform will be used for assessing the impact, effectiveness and safety of vaccines or other pharmaceutical health interventions. 

The observatory will initially include 20 hospitals in five European countries. The first proof-of-concept studies will be presented at the end of 2023. The observatory’s name, ARWEN ID, is derived from the Actionable Real World Evidence Network (ARWEN) and its focus on infectious diseases (IDs). 

Find us on LinkedIn to follow the progress of this new joint effort.   

👉 For more information on LOGEX, visit LOGEX.com 

👉 For more information on P95, visit p-95.com 

👉 For more information on ARWEN, visit arwen.eu